[1]
Näsman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Sparén P, Ye W, Dahlstrand H, Munck-Wikland E, Dalianis T. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? International journal of cancer. 2009 Jul 15:125(2):362-6. doi: 10.1002/ijc.24339. Epub
[PubMed PMID: 19330833]
[2]
Mirghani H, Sturgis EM, Aupérin A, Monsonego J, Blanchard P. Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review. Oral oncology. 2017 Apr:67():138-145. doi: 10.1016/j.oraloncology.2017.02.024. Epub 2017 Feb 28
[PubMed PMID: 28351568]
Level 1 (high-level) evidence
[3]
Weatherspoon DJ, Chattopadhyay A, Boroumand S, Garcia I. Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010. Cancer epidemiology. 2015 Aug:39(4):497-504. doi: 10.1016/j.canep.2015.04.007. Epub 2015 May 11
[PubMed PMID: 25976107]
[4]
Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, Roberts S. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region. Head & neck. 2013 May:35(5):747-55. doi: 10.1002/hed.22015. Epub 2012 Jan 20
[PubMed PMID: 22267298]
Level 1 (high-level) evidence
[5]
Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005 Feb:14(2):467-75
[PubMed PMID: 15734974]
Level 1 (high-level) evidence
[6]
Hassani S, Castillo A, Ohori J, Higashi M, Kurono Y, Akiba S, Koriyama C. Molecular Pathogenesis of Human Papillomavirus Type 16 in Tonsillar Squamous Cell Carcinoma. Anticancer research. 2015 Dec:35(12):6633-8
[PubMed PMID: 26637879]
[7]
Westra WH, Lewis JS Jr. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Oropharynx. Head and neck pathology. 2017 Mar:11(1):41-47. doi: 10.1007/s12105-017-0793-2. Epub 2017 Feb 28
[PubMed PMID: 28247229]
[8]
Lewis-Jones H, Colley S, Gibson D. Imaging in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. The Journal of laryngology and otology. 2016 May:130(S2):S28-S31
[PubMed PMID: 27841111]
[9]
Loh KS, Brown DH, Baker JT, Gilbert RW, Gullane PJ, Irish JC. A rational approach to pulmonary screening in newly diagnosed head and neck cancer. Head & neck. 2005 Nov:27(11):990-4
[PubMed PMID: 16136584]
[10]
Wong WL, Sonoda LI, Gharpurhy A, Gollub F, Wellsted D, Goodchild K, Lemon C, Farrell R, Saunders M. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers--an audit and review of published studies. Clinical oncology (Royal College of Radiologists (Great Britain)). 2012 Apr:24(3):190-5. doi: 10.1016/j.clon.2011.11.001. Epub 2011 Dec 17
[PubMed PMID: 22183080]
[11]
Mehanna H, McConkey CC, Rahman JK, Wong WL, Smith AF, Nutting C, Hartley AG, Hall P, Hulme C, Patel DK, Zeidler SV, Robinson M, Sanghera B, Fresco L, Dunn JA. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer. Health technology assessment (Winchester, England). 2017 Apr:21(17):1-122. doi: 10.3310/hta21170. Epub
[PubMed PMID: 28409743]
Level 1 (high-level) evidence
[12]
Hirshoren N, Olayos E, Callahan J, Lau E. PET/CT findings within the contralateral tonsil following unilateral tonsillectomy. The Laryngoscope. 2016 Nov:126(11):2480-2483. doi: 10.1002/lary.26023. Epub 2016 Apr 26
[PubMed PMID: 27114188]
[13]
Mehanna H, Evans M, Beasley M, Chatterjee S, Dilkes M, Homer J, O'Hara J, Robinson M, Shaw R, Sloan P. Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines. The Journal of laryngology and otology. 2016 May:130(S2):S90-S96
[PubMed PMID: 27841123]
[14]
Takes RP, Kaanders JH, van Herpen CM, Merkx MA, Slootweg PJ, Melchers WJ. Human papillomavirus detection in fine needle aspiration cytology of lymph node metastasis of head and neck squamous cell cancer. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2016 Dec:85():22-26. doi: 10.1016/j.jcv.2016.10.008. Epub 2016 Oct 27
[PubMed PMID: 27816020]
[15]
Moore EJ, Hinni ML. Critical review: transoral laser microsurgery and robotic-assisted surgery for oropharynx cancer including human papillomavirus-related cancer. International journal of radiation oncology, biology, physics. 2013 Apr 1:85(5):1163-7. doi: 10.1016/j.ijrobp.2012.08.033. Epub 2012 Nov 20
[PubMed PMID: 23182390]
[16]
Lee SY, Park YM, Byeon HK, Choi EC, Kim SH. Comparison of oncologic and functional outcomes after transoral robotic lateral oropharyngectomy versus conventional surgery for T1 to T3 tonsillar cancer. Head & neck. 2014 Aug:36(8):1138-45. doi: 10.1002/hed.23424. Epub 2013 Oct 17
[PubMed PMID: 23836492]
[17]
Patel AB, Hinni ML, Pollei TR, Hayden RE, Moore EJ. Severe prolonged dysphagia following transoral resection of bilateral synchronous tonsillar carcinoma. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2015 Nov:272(11):3585-91. doi: 10.1007/s00405-015-3540-x. Epub 2015 Feb 8
[PubMed PMID: 25663269]
[18]
Rokkjaer MS, Klug TE. Prevalence of synchronous bilateral tonsil squamous cell carcinoma: A retrospective study. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2018 Feb:43(1):1-6. doi: 10.1111/coa.12981. Epub 2017 Sep 25
[PubMed PMID: 28891195]
Level 2 (mid-level) evidence
[19]
Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, Lee A, Le QT, Maingon P, Nutting C, O'Sullivan B, Porceddu SV, Lengele B. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2014 Jan:110(1):172-81. doi: 10.1016/j.radonc.2013.10.010. Epub 2013 Oct 31
[PubMed PMID: 24183870]
Level 3 (low-level) evidence
[20]
Charbonneau N, Gélinas M, del Vecchio P, Guertin L, Larochelle D, Tabet JC, Soulières D, Charpentier D, Nguyen-Tân PF. Primary radiotherapy for tonsillar carcinoma: a good alternative to a surgical approach. The Journal of otolaryngology. 2006 Aug:35(4):227-34
[PubMed PMID: 17176797]
[21]
Chan KK, Glenny AM, Weldon JC, Furness S, Worthington HV, Wakeford H. Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy. The Cochrane database of systematic reviews. 2015 Dec 1:2015(12):CD010341. doi: 10.1002/14651858.CD010341.pub2. Epub 2015 Dec 1
[PubMed PMID: 26625332]
Level 1 (high-level) evidence
[22]
Onita B, Lester D R T, Iman A A, Jergin C, Shawn I. Comparison of high-dose Cisplatin-based chemoradiotherapy and Cetuximab-based bioradiotherapy for p16-positive oropharyngeal squamous cell carcinoma in the context of revised HPV-based staging. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology. 2018 Sep-Oct:23(5):451-457. doi: 10.1016/j.rpor.2018.08.007. Epub 2018 Sep 7
[PubMed PMID: 30210266]
[23]
Sehdev A, Zhao Y, Singh AK, Sharma N. Primary small cell carcinoma of the tonsil: a case report and review of the literature. Case reports in oncology. 2012 Sep:5(3):537-41. doi: 10.1159/000343676. Epub 2012 Oct 5
[PubMed PMID: 23139668]
Level 3 (low-level) evidence
[24]
Vasileiadis I, Sofopoulos M, Arnogiannaki N, Georgopoulos S. A Merkel-cell carcinoma metastatic to the tonsil: a case report and review of the literature. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 2013 Oct:71(10):1812.e1-6. doi: 10.1016/j.joms.2013.06.196. Epub 2013 Aug 1
[PubMed PMID: 23911145]
Level 3 (low-level) evidence
[25]
Massaccesi M, Morganti AG, Serafini G, Di Lallo A, Deodato F, Picardi V, Scambia G. Late tonsil metastases from renal cell cancer: a case report. Tumori. 2009 Jul-Aug:95(4):521-4
[PubMed PMID: 19856668]
Level 3 (low-level) evidence
[26]
Wang H, Chen P. Palatine tonsillar metastasis of rectal adenocarcinoma: a case report and literature review. World journal of surgical oncology. 2013 May 25:11():114. doi: 10.1186/1477-7819-11-114. Epub 2013 May 25
[PubMed PMID: 23705669]
Level 3 (low-level) evidence
[27]
Unsal M, Kutlar G, Sullu Y, Yurtlu S. Tonsillar metastasis of small cell lung carcinoma. The clinical respiratory journal. 2016 Nov:10(6):681-683. doi: 10.1111/crj.12275. Epub 2015 Mar 3
[PubMed PMID: 25620524]
[28]
Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA: a cancer journal for clinicians. 2017 Mar:67(2):122-137. doi: 10.3322/caac.21389. Epub 2017 Jan 27
[PubMed PMID: 28128848]
[29]
Charfi L, Jouffroy T, de Cremoux P, Le Peltier N, Thioux M, Fréneaux P, Point D, Girod A, Rodriguez J, Sastre-Garau X. Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer letters. 2008 Feb 18:260(1-2):72-8
[PubMed PMID: 18060686]
Level 3 (low-level) evidence
[30]
Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, Spencer S, Harris J, Chung CH, Ang KK. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Jun 10:30(17):2102-11. doi: 10.1200/JCO.2011.38.4099. Epub 2012 May 7
[PubMed PMID: 22565003]
[31]
Ward MJ, Thirdborough SM, Mellows T, Riley C, Harris S, Suchak K, Webb A, Hampton C, Patel NN, Randall CJ, Cox HJ, Jogai S, Primrose J, Piper K, Ottensmeier CH, King EV, Thomas GJ. Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. British journal of cancer. 2014 Jan 21:110(2):489-500. doi: 10.1038/bjc.2013.639. Epub 2013 Oct 29
[PubMed PMID: 24169344]
[32]
Rusthoven KE, Raben D, Ballonoff A, Kane M, Song JI, Chen C. Effect of radiation techniques in treatment of oropharynx cancer. The Laryngoscope. 2008 Apr:118(4):635-9. doi: 10.1097/MLG.0b013e31815fdf0e. Epub
[PubMed PMID: 18176348]
[33]
Achim V, Bolognone RK, Palmer AD, Graville DJ, Light TJ, Li R, Gross N, Andersen PE, Clayburgh D. Long-term Functional and Quality-of-Life Outcomes After Transoral Robotic Surgery in Patients With Oropharyngeal Cancer. JAMA otolaryngology-- head & neck surgery. 2018 Jan 1:144(1):18-27. doi: 10.1001/jamaoto.2017.1790. Epub
[PubMed PMID: 29075740]
Level 2 (mid-level) evidence
[34]
Guo T, Eisele DW, Fakhry C. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Cancer. 2016 Aug 1:122(15):2313-23. doi: 10.1002/cncr.29992. Epub 2016 May 6
[PubMed PMID: 27152637]